Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eugene R. Fluck"'
Autor:
Dodda Leelavathi, Soong T. Chiang, Kenneth C. Lasseter, Frank W. Janssen, Eugene R. Fluck, Jerome A. Hubsher
Publikováno v:
The Journal of Clinical Pharmacology. 24:515-522
Twelve normal subjects each received single 300-, 600-, and 1200-mg oral doses of oxaprozin according to a three-period crossover design. Total drug plasma concentrations did not increase in proportion to the dose administered. Total clearance (CIo)
Publikováno v:
Chemico-Biological Interactions. 15:219-231
Differential growth inhibition of two E. coli cultures was evaluated as a rapid screening technique for chemical carcinogens. Of the carcinogens tested, only "direct acting" carcinogens produced positive results. Furthermore, this test is not a quant
Publikováno v:
Drug Development Research. 3:91-99
Guanabenz (E-2,6-dichlorobenzylideneaminoguanidine acetate, Wy-8678) and its identified metabolites were tested for their ability to displace [3H]clonidine from the cerebral α2-receptors of rat and dog. The Kj's for inhibition of [3H]clonidine bindi
Publikováno v:
Agents and Actions. 12:211-215
Conventional dialysis cells were used in initial attempts to determine the binding characteristics of oxaprozin (4,5-diphenyl-2-oxazolepropionic acid, Wy-21,743). Equilibration required dialysis times up to 22 hours at 37 degrees C resulting in deter
Publikováno v:
Clinical Pharmacology & Therapeutics; Apr1982, Vol. 31 Issue 4, p509-515, 7p
Publikováno v:
Drug Development Research; 1983, Vol. 3 Issue 1, p91-99, 9p
Autor:
CHIANG, SOONG T., LASSETER, KENNETH C., FLUCK, EUGENE R., JANSSEN, FRANK W., LEELAVATHI, DODDA, HUBSHER, JEROME A.
Publikováno v:
Journal of Clinical Pharmacology; Nov1984, Vol. 24 Issue 11, p515-522, 8p
Publikováno v:
Agents & Actions; Apr1982, Vol. 12 Issue 1/2, p211-215, 5p
Keine ausführliche Beschreibung für'1962, Teil II: L - Z'verfügbar.